Fernando López‐Campos

1.3k total citations
61 papers, 441 citations indexed

About

Fernando López‐Campos is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Fernando López‐Campos has authored 61 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 23 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Cancer Research. Recurrent topics in Fernando López‐Campos's work include Prostate Cancer Treatment and Research (36 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Radiopharmaceutical Chemistry and Applications (17 papers). Fernando López‐Campos is often cited by papers focused on Prostate Cancer Treatment and Research (36 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Radiopharmaceutical Chemistry and Applications (17 papers). Fernando López‐Campos collaborates with scholars based in Spain, United States and Belgium. Fernando López‐Campos's co-authors include Felipe Couñago, Antonio J. Conde-Moreno, A. Hervás, M. Martín, Á. Montero, María E. Rodríguez-Ruiz, Juan Carlos García Pérez, Javier Díe Trill, Ignacio Melero and Javier Aristu and has published in prestigious journals such as Journal of Clinical Oncology, Pharmacology & Therapeutics and World Journal of Gastroenterology.

In The Last Decade

Fernando López‐Campos

54 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando López‐Campos Spain 10 184 174 94 83 74 61 441
Stanley I. Gutiontov United States 11 164 0.9× 179 1.0× 78 0.8× 111 1.3× 57 0.8× 29 439
Kendall Morrison United States 10 119 0.6× 87 0.5× 87 0.9× 76 0.9× 89 1.2× 20 397
Alessandra R. Garcia United States 4 109 0.6× 97 0.6× 64 0.7× 102 1.2× 46 0.6× 4 458
Xiumei Ma China 12 124 0.7× 110 0.6× 34 0.4× 91 1.1× 181 2.4× 34 473
Zhongzhen Guan China 8 233 1.3× 133 0.8× 48 0.5× 73 0.9× 142 1.9× 26 600
J. Good United Kingdom 8 95 0.5× 73 0.4× 58 0.6× 33 0.4× 98 1.3× 14 296
Zhengchao Zhang China 12 308 1.7× 63 0.4× 53 0.6× 94 1.1× 118 1.6× 28 588
Min Du China 13 146 0.8× 83 0.5× 95 1.0× 101 1.2× 111 1.5× 37 550
Christian Maare Denmark 11 262 1.4× 88 0.5× 47 0.5× 71 0.9× 160 2.2× 41 459
Maarten C. Jansen Netherlands 9 181 1.0× 101 0.6× 49 0.5× 142 1.7× 28 0.4× 10 520

Countries citing papers authored by Fernando López‐Campos

Since Specialization
Citations

This map shows the geographic impact of Fernando López‐Campos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando López‐Campos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando López‐Campos more than expected).

Fields of papers citing papers by Fernando López‐Campos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando López‐Campos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando López‐Campos. The network helps show where Fernando López‐Campos may publish in the future.

Co-authorship network of co-authors of Fernando López‐Campos

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando López‐Campos. A scholar is included among the top collaborators of Fernando López‐Campos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando López‐Campos. Fernando López‐Campos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alba, Aranzazu González del, José Ángel Arranz, Enrique Gallardo, et al.. (2025). Therapeutic Alliances for Optimizing the Management of Patients with Prostate Cancer: SOGUG Multidisciplinary Expert Panel Recommendations. Cancers. 17(19). 3208–3208.
2.
Tombal, Bertrand, F. Gómez-Veiga, Á. Gómez-Ferrer, et al.. (2024). A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). European Urology Oncology. 7(5). 1051–1060. 5 indexed citations
3.
López‐Campos, Fernando, et al.. (2024). Current landscape of gastrointestinal radiation oncology in Spain: a multicenter real-life survey and comparison with key clinical guidelines. Reports of Practical Oncology & Radiotherapy. 29(3). 340–347.
4.
Rades, Dirk, Darejan Lomidze, Fernando López‐Campos, et al.. (2024). Radiotherapy with 15 × 2.633 Gy vs. 20 × 2.0 Gy in Patients with Malignant Spinal Cord Compression and Favorable Survival Prognoses: A Secondary Analysis of the RAMSES-01 Trial. Cancers. 16(20). 3436–3436. 1 indexed citations
5.
López‐Campos, Fernando, et al.. (2024). Impact of Dose-Escalated Chemoradiation on Pathological Complete Response in Patients with Locally Advanced Rectal Cancer. Cancers. 16(18). 3170–3170. 1 indexed citations
6.
Gómez‐Iturriaga, Alfonso, D. Büchser, Fernando López‐Campos, & Xavier Maldonado. (2024). Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities. Clinical and Translational Radiation Oncology. 45. 100733–100733. 4 indexed citations
7.
López‐Campos, Fernando, et al.. (2023). Treatment of metastatic squamous cell carcinoma arising in sacrococcygeal pilonidal sinus: a case report series. Frontiers in Medicine. 10. 1248894–1248894. 1 indexed citations
8.
Gajate, Pablo, et al.. (2023). Stereotactic body radiation therapy for kidney cancer. Where do we stand?. International Journal of Urology. 30(5). 437–445. 3 indexed citations
9.
López‐Campos, Fernando, Xavier Maldonado, Elena Moreno, et al.. (2023). Novel Approaches in the Systemic Management of High-Risk Prostate Cancer. Clinical Genitourinary Cancer. 21(6). e485–e494. 5 indexed citations
10.
Rivas, Juan Gómez, D. Büchser, Thomas Zilli, et al.. (2023). Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?. Clinical Genitourinary Cancer. 22(1). 56–66. 4 indexed citations
11.
Recio, Manuel, Fernando López‐Campos, Israel J. Thuissard, et al.. (2023). Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer. World Journal of Urology. 41(12). 3829–3838. 2 indexed citations
12.
Scorsetti, Marta, et al.. (2022). Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?. Clinical Oncology. 35(3). 163–176. 2 indexed citations
13.
López‐Campos, Fernando, Pablo Gajate, Nuria Romero-Laorden, et al.. (2022). Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions. Biomedicines. 10(3). 537–537. 15 indexed citations
14.
Conde-Moreno, Antonio J., Aranzazu González del Alba, Fernando López‐Campos, et al.. (2022). Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer. Clinical & Translational Oncology. 25(4). 897–911. 2 indexed citations
15.
López‐Campos, Fernando, et al.. (2021). Current role of nanoparticles in the treatment of lung cancer. Journal of Clinical and Translational Research. 7(2). 140–155. 66 indexed citations
16.
Rodríguez‐Vida, Alejo, A. Rodríguez Alonso, Fernando López‐Campos, et al.. (2021). Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-Analysis. Clinical Genitourinary Cancer. 20(2). 197.e1–197.e10. 5 indexed citations
17.
Hervás, A., et al.. (2020). Metformin and statins: a possible role in high-risk prostate cancer. Reports of Practical Oncology & Radiotherapy. 25(2). 163–167. 5 indexed citations
18.
López‐Campos, Fernando, et al.. (2018). Nanoparticles applied to cancer immunoregulation. Reports of Practical Oncology & Radiotherapy. 24(1). 47–55. 25 indexed citations
19.
Rodríguez-Ruiz, María E., Inmaculada Rodríguez, Fernando López‐Campos, et al.. (2018). Immune mechanisms mediating abscopal effects in radioimmunotherapy. Pharmacology & Therapeutics. 196. 195–203. 55 indexed citations
20.
López‐Campos, Fernando, et al.. (2016). Notificações de doenças em suídeos efetuadas ao serviço veterinário oficial estadual Do Rio Grande do Sul no primeiro semestre de 2015. Revista de Educação Continuada em Medicina Veterinária e Zootecnia do CRMV-SP. 14(2). 87–87. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley I. Gutiontov Breakdown of academic impact, for papers by Kendall Morrison Breakdown of academic impact, for papers by Alessandra R. Garcia Breakdown of academic impact, for papers by Xiumei Ma Breakdown of academic impact, for papers by Zhongzhen Guan Breakdown of academic impact, for papers by J. Good Breakdown of academic impact, for papers by Zhengchao Zhang Breakdown of academic impact, for papers by Min Du Breakdown of academic impact, for papers by Christian Maare Breakdown of academic impact, for papers by Maarten C. Jansen
Rankless by CCL
2026